Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lactate Added to Critical Care Analyzer Menu

By LabMedica International staff writers
Posted on 30 Apr 2012
A lactate assay has become available for cartridge-based critical care testing at the Point of Care (POC). More...
Lactate joins an already extensive assay menu that includes blood gas, electrolytes, metabolites, and CO-oximetry.

Siemens (Erlangen, Germany) continues to expand the assay menu of its RAPIDPoint 500 critical care analyzer. The easy-to-use RAPIDPoint 500 system uses Siemens technology to deliver rapid and accurate test results in approximately 60 seconds.

The value of measuring lactate levels is expanding. Though generally considered a nonspecific biomarker, knowing lactate levels early in a patient’s presentation can provide valuable information to help guide patient assessment and treatment.

It can be particularly useful in the Intensive Care Unit (ICU) and Emergency Department (ED) settings where the presentation of symptoms may be inconclusive while diseases progress rapidly with severe pathology; lactate testing can open a critical window for early intervention when treatment is most likely to be successful. This allows clinicians to quickly gain diagnostic information for treatment planning.

Afia Boamah, blood gas and stratus CS product manager at Siemens Healthcare Diagnostics, stated, “The addition of Lactate to the already extensive assay range on the RAPIDPoint 500 follows an extremely successful Controlled Release Program. Over 21,000 samples were run with zero cartridge failures attributable to the lactate sensor. Such results underpin the confidence we have in our cartridge based technology and the functionality it adds to the RAPIDPoint 500 System.”

The RAPIDPoint 500 Lactate Cartridge received the CE Marking, December 16, 2011. RAPIDPoint 500 Analyzer received the CE Marking, September 26, 2011.

Related Links:

Siemens Healthcare Diagnostics



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.